Wild trading ✓

[text] $ASTS I have a theory... Chris Sambar left ATT to become CEO of a storage company. Those of us around for a while thought this was strange. Additionally, we selfishly hated it because he is a huge advocate of ASTS. Well... I wonder if there was a clause in his contract that he

[image] $ASTS had an absolute monster day Price is still holding above the 0.382 fib at $105, and seeing that accumulation in wave 2… feels really bullish You know how it goes the longer a stock consolidates, the crazier the breakout. Feels like this one’s just coiling up, ready to

[text] $IBRX I hope all you investors realize this company will be the “standard of care” for cancer within the next 5 years. Be patient. Big Pharma and the corrupt FDA can only stall this company for so long. Under $10 per share is an absolute generational wealth building price. Keep

[image] $ASTS The second facility in Odessa just a few minutes from the first had hundreds of cars and it was packed like sardines! I barely was able to navigate! It was super saturated. I didn’t see a single spot available and I think a few cars were actually parked where they

[text] $NWBO Say what ? Total GBM and rGBM market is 50,000 patients annually. Conserva(vely estimating that a course of DCVax is US$175,000 per year then we come to an annual revenue from GBM and rGBM alone of $5.77Bn with 2/3 market penetration. By using a very reasonable forward

[text] $ASTS 10 Commandments of the AST Investor: 1. Believe in the vision 2. Do not worship the stock price 3. Value the technical achievements 4. Respect your thesis 5. Do not sell out of fear 6. Do not buy out of euphoria 7. Do not spread rumors 8. Accept the timelines of space 9.

[text] $NIO even though the US fund managers are not supposed to buy Nio, when you have good news day after day after day, someone is eventually going to break rank ( = greed prevails) and then FOMO hits everyone ( = God's candle). Nio is a powder keg right now. Light that bitch.

[image] $NIO unlike shorts and paid trolls I’m not afraid to share my position in Nio this stock is indeed very undervalued

[text] $NIO I don’t know, but they are f-ing with the stock if you ask me. They seem to really want to shake out as much of the retail sector as much as possible. It seems it is totally controlled. People are playing right into as you read posts that they have had enough, tired and

[text] $IBRX So plan for a squeeze at whatever number you like but with the number of short shares out there I think the squeeze could be quite high. Well over $100. The squeeze might only last for days or a week until those sick fuckers loose their ass and are gone. But it could get

[text] $NWBO Seriously how do we get worked up over a quarter penny or less movement, this is just involuntary breathing anymore. Who gives a shit soemone bought 20K shares or sold 100K. Nothing is going to happen without news, actual news, not so and so got hired at this place or

[text] $NWBO Had a great dream last night. 1. MHRA approved DCVax 2. Orbis was implemented 3. White House approves DCvax 4. Big Pharma,s calling Linda to partner 5. DJT with Dr. OZ, Kennedy and Braelyn in Oval Office with big announcement to the world about a new vaccine for

[text] $NWBO I still believe the delay is entirely completing the leukapheresis clinic buildout and licensing. Notice there hasn't been a PR or 8-K regarding either? I believe after finding the location in Q4 of 2025, a 6 month buildout and licensing "by June" was very optimistic. A

[text] $NWBO We will get approval? Yes When? Don’t know. Are they slow walking this? Without a doubt. Are people dying while waiting? Without a doubt. Do they care? It seems like a big fat NO they don’t. Are they being pressured by BP and Hedge funds? Absolutely. Does that make MHRA

[text] $NWBO UCLA’s DCVax-L/Keytruda study reported HR 0.32 and p<0.0006 in recurrent IDH-wild-type GBM—a 68% lower hazard of death with vaccine-first sequencing. This is the “emperor of cancers,” an immunologically cold tumor, unlike hotter melanoma, where Keytruda already works more

[text] $VKTX I have not listened to the CC yet but anyone talking garbage because he doesn’t have data doesn’t understand he does not control its release. The last thing anyone should want is a CEO trying to undermine trial data. It’s easy to bitch and moan when you’re not the one

[text] $NWBO Does anyone think that NWBO will be mentioned at tomorrow's presentation by Dr Prins in Rome at EANO? Personally I do not. This is a UCLA trial and everything says ALT-DC (even though DCVAX-L is the NWBO commercial name). The trial results should be amazing and I look

[text] $VKTX there is no bear thesis here. best in industry efficacy, impressive tolerability, the best and only dual agonist pill, infrequent/maintenance dosing, and a very impressive amylin on the way. whether you or the market realize it, this company has the best and most flexible

[text] $TGTX - Looking at the clinical trial update page plus ai On September 9, 2026, TG Therapeutics transitioned its azer-cel trial into Phase 2, expanding enrollment to 100 patients. This milestone indicates that early cohorts cleared crucial safety benchmarks without severe

[text] $SLS The Core 13 Rules: SELLAS officially lists exactly 13 full-time W-2 employees in its SEC profiles. The Executive 5 & Operational 2: If any of the 5 known executive officers or 2 internal operational directors left, an SEC Form 8-K would have legally dropped instantly. None